Quotient Clinical , the early phase drug development services provider, today announces that it has acquired SeaView Research , expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.
Category: Pharmacology
Unique Nanoparticle Properties Confound Fluorescent Based Assays…
Dreher, K. AND W. Polk. Unique Nanoparticle Properties Confound Fluorescent Based Assays Widely Employed in Their In Vitro Toxicity Testing and Ranking.
Skin Cancer Breakthrough 2017: Melanoma Spread Reduced By Up To 90% With New Man-Made Compound
Skin cancer is the most common form of cancer is the world, and although melanoma is a more rare form, it is also the most deadly . New research from Michigan State University may soon change this.